Showing results (1781-1790 of 2,464) with videos related to
Sort By:
Pageof 247
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Synthesis of 3'-ureidoadenosine analogues and their binding affinity to the A3 adenosine receptorMoon Woo Chun, Hyouk Woo Lee, Ae Yil Kim, et al.Biorxiv : the Preprint Server for Biology|July 16, 2025
Integrated Omics Approach to Delineate the Mechanisms of Doxorubicin-Induced CardiotoxicityMohamed S Dabour, Ibrahim Y Abdelgawad, Bushra Sadaf, et al.Dermatology and Therapy|July 29, 2025
Brodalumab: Seven-Year US Pharmacovigilance ReportMark G Lebwohl, John Y Koo, April W Armstrong, et al.Drug Development Research|March 15, 2013
Activation and Desensitization of Rat A3-Adenosine Receptors by Selective Adenosine Derivatives and Xanthine-7-RibosidesKyung-Sun Park, Carsten Hoffmann, Hea Ok Kim, et al.Journal of Clinical Lipidology|February 19, 2013
Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical settingMark J Cziraky, Vincent J Willey, James M McKenney, et al.Journal of Medicinal Chemistry|November 26, 2014
In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonistsDilip K Tosh, Amanda Finley, Silvia Paoletta, et al.Bioorganic & Medicinal Chemistry Letters|August 26, 2015
Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y₁₄ receptorEvgeny Kiselev, Ramachandran Balasubramanian, Elisa Uliassi, et al.Journal of Intellectual Disability Research : JIDR|December 27, 2022
Confirmatory factor analysis of the BRIEF2 in a sample of youth with Down syndromeA Soltani, E K Schworer, L A Jacobson, et al.Obesity Pillars|May 6, 2024
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024Harold Edward Bays, Carol Kirkpatrick, Kevin C Maki, et al.Dermatology and Therapy|May 9, 2024
Brodalumab: 5-Year US Pharmacovigilance ReportMark G Lebwohl, John Y Koo, April W Armstrong, et al.Pageof 247